My postdoctoral research at UCSF has focused on the development of a Bayesian-supported framework for decision-making in adaptive Phase II trials; work performed in collaboration with the UNITE4TB public-private consortium to advance Phase II clinical trial design and identify novel tuberculosis (TB) therapeutics. TB is the leading cause of death from an infectious disease worldwide. Though treatable and curable, current therapeutic regimens have been ineffective in controlling the spread of TB.